Clinical Trial Update: Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis [Phase 2]

View source ↗

Summary

The document describes an ongoing Phase 2 clinical trial evaluating HS-10374 versus placebo for active psoriatic arthritis, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• HS-10374

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Psoriatic Arthritis | Phase 2 | Status: RECRUITING